Highlights

- First purchase order secured with global footwear company Flux Footwear for graphene-enhanced athletic and leisure footwear

- US-based customer becomes the third footwear client in First Graphene's growing global portfolio to leverage PureGRAPH®'s performance benefits

- Purchase order marks FGR's first commercial production application in global sports shoe market, valued at more than US$150 billion[1]

SYDNEY, Oct. 6, 2026 /PRNewswire/ -- First Graphene Limited (ASX: FGR; "First Graphene" or "the Company") (FRA:M11) (OTCQB:FGPHF) is pleased to announce it has secured its first purchase order from US-based footwear company Flux Footwear ("Flux").

Flux Footwear will incorporate PureGRAPH® into its athletic and leisure footwear range, delivering strength and durability enhancements to the brand's Graphene XT performance gym shoes.

The purchase order will be the Company's first production application within the sporting and athletic footwear sector, building on previously announced success in the work and safety footwear industry.

Following recent development work, PureGRAPH® was selected for use across Flux's graphene-enhanced footwear range and will progressively replace existing graphene models as production requirements increase.

Driving performance with advanced materials

Flux is an innovative US performance footwear company already using graphene as part of its product innovation strategy through its Graphene-Pro™ footwear range.

Graphene is used in high-wear areas of the outsole to enhance durability, abrasion and tear resistance, grip and flexibility without unnecessary additional weight. PureGRAPH®'s proven performance benefits will ensure the quality of Flux's footwear range is maintained.

Flux has a well-established global customer base, delivering graphene-enhanced footwear primarily into the US market.

The first production order with First Graphene will establish a pathway for penetration into these markets through ongoing PureGRAPH® supply as Flux progresses production of its graphene-enhanced footwear.

Building on established success

The production order with Flux builds on First Graphene's established technical and commercial experience in the footwear segment.

The Company has previously progressed PureGRAPH® through development, independent testing and commercial production in work and safety footwear, including collaborations with Australian safety footwear manufacturer Steel Blue and Indonesian mining work boot manufacturer PT Alasmas Berkat Utama.

PureGRAPH® was successfully incorporated into both types of footwear, targeting improvements in abrasion resistance, tear strength and durability, and subsequently progressed into commercial production.

The Flux order represents the next evolution of this established application, extending First Graphene's formulation knowledge and commercial experience from industrial and safety footwear into the substantially larger sporting, athletic and leisure footwear segment.

While this initial order is not itself financially material to the Company, importantly it reinforces the Company's ability to transfer an established PureGRAPH® application into a new customer, product category and geographic market, which is an important component of First Graphene's commercialisation strategy.

The global sports shoes market is anticipated to be valued at more than US$212 billion by 20351, representing a strong increase in demand for more durable and longer-lasting sports shoes.

First Graphene Managing Director and CEO Michael Bell said:

"The first production order for Flux Footwear represents another important commercial milestone for First Graphene, delivering a new revenue stream while reinforcing the Company's growing market presence built through years of strategic partnerships and product development.

This commercial agreement with a globally renowned company will provide potential pathways to recurring PureGRAPH® production demand while also further expanding our presence in the US.

Our collaboration with Flux also reflects the overarching rising global demand for more durable, high-performing footwear, as consumers and manufacturers increasingly prioritise longevity, performance and sustainability.

Most importantly, this progression from development and validation to production order and potential recurring revenue is exactly what First Graphene is focused on delivering from our commercial strategy.

We look forward to working with Flux as it continues to develop innovative and high-performing footwear using our proven PureGRAPH® products."

This announcement has been approved by the Chairman.

References

SOURCE First Graphene Limited

Share this article

PUNE, India, Oct. 6, 2026 /PRNewswire/ -- The Global Feminine Hygiene Products Market was valued at USD 43.04 Billion in 2025 and is projected to grow at a CAGR of 6.43% from 2026 to 2034, reaching USD 75.41 Billion by 2034, according to a new analysis by Maximize Market Research.

Explore 129 market data tables and 60 figures across 306 pages, along with a detailed Table of Contents covering the Global Feminine Hygiene Products Market.

Global Feminine Hygiene Products Market Size & Forecast

Market Size (Base Year 2025): USD 43.04 Billion

Forecast Market Size (2034): USD 75.41 Billion

CAGR (2026–2034): 6.43%

Base Year: 2025

Forecast Period: 2026–2034

Historical Period: 2020–2025

Global Feminine Hygiene Products Market Overview

The Global Feminine Hygiene Products Market continues to expand as awareness of menstrual health, personal hygiene, product safety, affordability, and access to sanitary products improves across developed and developing countries. Feminine hygiene products are widely used for menstrual protection, intimate hygiene, comfort, and daily personal care, with demand supported by sanitary pads, tampons, menstrual cups, panty liners, shields, internal cleansers, sprays, and other products. Market growth is also being driven by rising disposable incomes, increasing female education, urbanization, greater participation of women in the workforce, wider retail distribution, and growing awareness of safe menstrual hygiene practices.

The market is increasingly shaped by sustainable feminine hygiene products, reusable menstrual products, organic and biodegradable materials, smart feminine care technologies, e-commerce, online retail, and product innovation focused on comfort, leak protection, absorbency, discretion, and convenience. Asia Pacific remains the leading regional market, supported by its large female population, rising awareness, improving affordability, expanding e-commerce, and strong demand across India and China. North America and Europe remain important markets for premium, organic, fragrance-free, reusable, and sustainable feminine hygiene products, while the Middle East & Africa and South America continue to offer significant market opportunities as product access, education, and retail infrastructure improve.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.maximizemarketresearch.com/request-sample/221943/

The Global Feminine Hygiene Products Market is evolving as consumers increasingly seek safe, comfortable, affordable, sustainable, and convenient menstrual-care solutions. Sanitary pads continue to dominate demand, while reusable products, menstrual cups, biodegradable materials, e-commerce, smart feminine care technologies, and public menstrual-health initiatives are creating new growth opportunities. Companies that improve product performance, affordability, sustainability, distribution reach, digital access, and consumer education are likely to shape the Feminine Hygiene Products Market through 2034.

Feminine Hygiene Products Market Growth Drivers, Opportunities & Key Highlights

The Global Feminine Hygiene Products Market is expanding as menstrual health awareness, rising disposable incomes, urbanization, female education, growing participation of women in the workforce, and wider product availability continue to support demand. Sanitary pads remain the leading product category because of their affordability, convenience, ease of use, and strong retail penetration, while tampons, menstrual cups, reusable pads, panty liners, and other feminine care products are gaining attention among consumers seeking comfort, sustainability, and personalized menstrual-care solutions.

New market opportunities are emerging through organic and biodegradable products, reusable menstrual care, smart feminine hygiene technologies, e-commerce, quick-commerce, public menstrual-health initiatives, and improved rural distribution. Recent developments include Kimberly-Clark's redesigned Kotex portfolio with Gravity™ Core and 5X System technologies, Kimberly-Clark India and UNICEF India's menstrual-health initiative across nine Indian states, and HLL Lifecare's upgraded menstrual cup manufacturing facility and compostable sanitary napkins.

Key Market Highlights

- USD 43.04 Billion: Market size in 2025

- USD 75.41 Billion: Projected market size by 2034

- 6.43% CAGR: Growth during 2026–2034

- Asia Pacific: Leading regional market

- 45%+ share: Asia Pacific share of the global sanitary pads market in 2025

- Sanitary Pads: Leading product type

- Disposable: Leading nature segment

- Offline: Leading distribution channel

- 500 million: Women and girls globally lacking adequate access to menstrual hygiene products and facilities

- 2.88 million: Adolescent girls, women, and infants targeted through the Kimberly-Clark India and UNICEF India initiative

India Feminine Hygiene Products Market Strengthens with Menstrual Health Initiative

In India, the Feminine Hygiene Products Market gained momentum in March 2026 as Kimberly-Clark India and UNICEF India announced a collaboration to improve menstrual and maternal health services across nine Indian states, targeting around 2.88 million adolescent girls, women, and infants. The initiative focuses on improving menstrual-health awareness, access to hygiene products, and related health services, supporting wider adoption of safe feminine hygiene solutions. This development reflects India's growing focus on menstrual-health education, product accessibility, and public-private collaboration, while strengthening long-term opportunities for sanitary pads, reusable products, and other feminine hygiene solutions.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/221943/

The Global Feminine Hygiene Products Market is segmented by Nature, Product Type, Distribution Channel, and Region.

By Nature, Disposable Feminine Hygiene Products hold the leading position in 2025 due to their convenience, affordability, widespread availability, and strong consumer preference for easy-to-use menstrual-care solutions. Disposable products are widely available through supermarkets, drugstores, convenience stores, and other retail channels. Reusable Feminine Hygiene Products are gaining traction as consumers increasingly prefer sustainable, cost-effective, and eco-friendly options such as menstrual cups and washable pads.

By Product Type, Sanitary Pads hold the dominant position in 2025 because of their ease of use, comfort, affordability, and strong penetration across developed and developing markets. Tampons and Menstrual Cups are also gaining adoption as awareness of menstrual health, sustainability, convenience, and reusable feminine hygiene solutions increases. Panty Liners and Shields, Internal Cleansers and Sprays, and other feminine hygiene products continue to support broader intimate-care demand.

Asia Pacific Leads the Feminine Hygiene Products Market as Menstrual Health Awareness and Product Access Strengthen

Asia Pacific remains the leading region in the Global Feminine Hygiene Products Market, supported by its large female population, rising disposable incomes, improving menstrual-health awareness, urbanization, and expanding access to hygiene products across urban and semi-urban areas. India and China are major contributors to regional demand, while stronger e-commerce penetration and wider retail distribution are improving product accessibility. Sanitary pads remain the dominant product category, while demand for organic, biodegradable, reusable, and sustainable feminine hygiene products is also increasing across the region.

North America remains a significant market due to high product penetration, strong consumer awareness, established retail networks, and growing demand for premium, organic, fragrance-free, and sustainable products. Europe is a mature market with increasing interest in reusable menstrual products, biodegradable materials, and reduced-plastic solutions. Middle East & Africa is developing through improving menstrual-health awareness, female education, urbanization, public initiatives, and better retail access, while South America continues to grow through increasing awareness, modern retail expansion, and demand for affordable and environmentally friendly menstrual-care products.

Global Feminine Hygiene Products Market Competitive Landscape

The Global Feminine Hygiene Products Market is highly competitive, with major companies focusing on product innovation, absorbency, comfort, leak protection, affordability, sustainability, brand strength, and wider retail and digital distribution. Competition is increasingly centered on sanitary pads, tampons, menstrual cups, panty liners, reusable products, organic materials, biodegradable products, and premium feminine-care solutions. Major players include Procter & Gamble, Kimberly-Clark, Unicharm, Kenvue, Essity, Ontex, Edgewell Personal Care, Unilever, Kao Corporation, and Hengan International. Recent developments show that competition is shifting toward advanced product technologies, sustainable menstrual care, menstrual-health awareness, and omnichannel expansion. In 2026, Kimberly-Clark introduced a redesigned Kotex portfolio with Gravity™ Core and 5X System technologies, while HLL Lifecare upgraded its menstrual cup manufacturing facility and introduced Happy Days Compostable Sanitary Napkins. Stayfree also emphasized premiumization and expansion across traditional retail, e-commerce, and quick-commerce channels, reflecting stronger competition in product performance, sustainability, accessibility, and consumer convenience.

LONDON, Oct. 6, 2026 /PRNewswire/ -- The "Cell Culture Monitoring Biosensors Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2032" report has been added to the Credence Research Inc. offering.

The global Cell Culture Monitoring Biosensors Market was valued at USD 413.8 million in 2024 and is projected to reach USD 906.56 million by 2032, registering a CAGR of 10.3% during the forecast period. Market growth is supported by rising demand for real-time, non-invasive cell analysis across biologics development, cell therapy, high-throughput research and bioprocess control. Optical, electrochemical and microfluidic biosensors are increasingly integrated with automated culture platforms to improve monitoring accuracy, reduce manual sampling and detect process deviations earlier.

Key Takeaways

- The Cell Culture Monitoring Biosensors Market is projected to increase from USD 413.8 million in 2024 to USD 906.56 million by 2032 at a CAGR of 10.3%.

- Optical biosensors led the technology segment with about 39% share in 2024, supported by strong use in real-time and label-free cell analysis.

- Cell proliferation and viability monitoring accounted for nearly 42% share, reflecting broad use in drug development, toxicity testing and biopharmaceutical production.

- Pharmaceutical and biotechnology companies represented roughly 51% of end-user demand in 2024.

- North America leads with about 38% share, followed by Europe at nearly 29% and Asia Pacific at around 23%.

- Microfluidic miniaturization, AI-enabled predictive monitoring and high-throughput automation are major technology trends shaping product development.

Scope & Segmentation – Cell Culture Monitoring Biosensors Market

The report provides a comprehensive analysis of the global Cell Culture Monitoring Biosensors Market, covering revenue forecasts through 2032. It evaluates market drivers, technology trends, adoption challenges, growth opportunities, competitive positioning and regional demand across research and biopharmaceutical environments.

The study examines how biosensors are used to track cell proliferation, viability, metabolism and differentiation without disrupting culture conditions. It also assesses the expanding use of optical, electrochemical, mechanical and microfluidic platforms across pharmaceutical and biotechnology companies, academic institutes and contract research or service providers.

The Cell Culture Monitoring Biosensors Market is segmented based on technology, application, end user and geography.

- By Technology, the market includes Optical Biosensors, Electrochemical Biosensors, Mechanical Biosensors, Microfluidic Biosensors and Others.

- By Application, the market includes Cell Proliferation & Viability Monitoring, Cell Metabolism Monitoring, Cell Differentiation Monitoring, Cell-Based Assays and Others.

- By End User, the market includes Pharmaceutical & Biotechnology Companies, Academia & Research Institutes, CROs & Service Providers and Others.

- By Geography, the market includes North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cell-culture-monitoring-biosensors-market

Why This Report Matters

- The report provides a detailed view of biosensor technologies supporting real-time cell culture analysis, process control and high-throughput research.

- It helps decision-makers understand how biologics, cell therapy and regenerative medicine pipelines are increasing the need for continuous monitoring.

- The study evaluates the role of microfluidics, AI analytics and automation in reducing manual sampling, improving consistency and accelerating laboratory workflows.

- For biopharma companies, CROs, research institutes, technology suppliers and investors, the report provides intelligence to support platform selection, product strategy and market expansion.

Market Overview

• Industry Landscape and Value Chain Assessment

• Supply-Side Evaluation

• Demand-Side Evaluation

• Stakeholder Mapping

• Porter's Five Forces Review

• PESTLE Environment Assessment

• Market Forecast and Future Direction

• Short-Term Forecast, 0–2 Years

• Mid-Term Forecast, 3–5 Years

• Long-Term Forecast, 5–10 Years

• Market Entry and Expansion Strategy

Market Insights

• Customer and End-User Analysis

• Technology Performance Assessment

• Growth Opportunity Assessment

• Bioprocess and Research Workflow Review

• Pricing and Adoption Cost Analysis

• Regulatory and Quality Control Assessment

• Automation and Data Integration Analysis

• Risk and Integration Challenge Assessment

• Investment Return and Market Expansion Assessment

Key Attributes

Segmentation

By Technology

• Optical Biosensors

• Electrochemical Biosensors

• Mechanical Biosensors

• Microfluidic Biosensors

• Others

By Application

• Cell Proliferation & Viability Monitoring

• Cell Metabolism Monitoring

• Cell Differentiation Monitoring

• Cell-Based Assays

• Others

By End User

• Pharmaceutical & Biotechnology Companies

• Academia & Research Institutes

• CROs & Service Providers

• Others

By Geography

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Market Growth Driven by Real-Time Cell Analysis and Expanding Biopharmaceutical Pipelines

Laboratories and bioprocessing facilities are shifting from periodic manual sampling toward continuous biosensor-based monitoring. Real-time measurement of cell health, growth and metabolic status can improve culture consistency, reduce contamination risk and shorten experimental decision cycles.

The expansion of biologics, gene therapies and cell therapies further strengthens demand. Sensitive workflows involving CAR-T cells, stem cells and monoclonal antibody production require tighter control of viability, purity and functional performance, increasing the value of high-frequency monitoring.

Regulatory expectations for process validation and manufacturing consistency also support adoption. Biosensors can provide richer process data and enable earlier intervention when culture conditions move outside expected ranges, improving confidence in development and scale-up workflows.

Automation, Microfluidics and AI Expand Biosensor Capabilities

Automation is increasing the value of cell culture biosensors by linking sensing platforms with robotic workstations, high-throughput screening systems and digital bioprocess environments. Integrated monitoring can reduce manual handling while improving the consistency of repeated assays.

Microfluidic and miniaturized biosensors are creating opportunities for lower-volume analysis, rapid screening and single-cell workflows. These platforms can reduce reagent consumption while enabling high-precision measurements in compact formats suited to research and early-stage process development.

AI-based analytics are adding predictive capabilities by identifying patterns in growth, nutrient levels and metabolic behavior. As laboratories generate larger continuous datasets, machine learning can support anomaly detection and earlier corrective action, creating a path toward more automated culture management.

Market Challenges Include High Platform Costs and Complex System Integration

Advanced optical and microfluidic biosensors can require expensive instruments, specialized consumables and high-performance imaging or sensing components. These costs can restrict adoption among smaller laboratories and academic centers with limited capital budgets.

Recurring consumable expenses also influence the economics of broader deployment. Buyers must weigh the value of continuous monitoring against assay volume, process criticality and the cost of alternative analytical workflows.

Integration with existing bioreactors, microfluidic chips and automated workstations can be technically demanding. Labs may require custom interfaces, validation work and workflow changes before new biosensors can be used consistently across established processes.

Calibration, data compatibility and specialist expertise add further operational complexity. Suppliers that simplify integration and provide strong technical support will be better positioned to expand adoption across regulated and research-driven environments.

Key Player Analysis

• Lifeonics Ltd.

• Sarissa Biomedical Ltd.

• Nova Biomedical

• C-CIT Sensors AG

• Conductive Technologies Inc.

• Cardea

• Roche

• Lonza

Recent Industry Developments

- In 2025, Roche announced an investment of up to USD 550 million to expand its diagnostics manufacturing hub in Indianapolis, increasing capacity across its diagnostics operations.

- In 2023, Lonza introduced TheraPEAK T-VIVO Cell Culture Medium, a chemically defined formulation designed to support and accelerate CAR-T cell manufacturing workflows.

Report Coverage

- The research report offers an in-depth analysis based on Technology, Application, End User and Geography. It details leading market players and provides an overview of their businesses, product offerings, investments and key applications.

- The report includes insights into the competitive environment, SWOT analysis, current technology trends, major market drivers and adoption constraints.

- The study further assesses bioprocess automation, regulatory requirements, data integration and technological advances influencing the Cell Culture Monitoring Biosensors Market.

- It provides strategic recommendations for new entrants and established companies seeking to navigate the evolving market for real-time cell culture monitoring technologies.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cell-culture-monitoring-biosensors-market

Shape Your Report to Specific Countries or Regions and Enjoy 30% Off!

Customize Now

Related Reports –

https://www.

Mercy Medical Center's Tyanna O'Brien Center for Women's Imaging Earns Comprehensive Breast Imaging Center Accreditation

BALTIMORE, Oct. 6, 2026 /PRNewswire/ -- The American College of Radiology (ACR) has recognized Mercy Medical Center's Tyanna O'Brien Center for Women's Imaging as a Comprehensive Breast Imaging Center (CBIC), a designation that recognizes breast imaging facilities that achieve excellence through participation in the ACR's rigorous breast-imaging accreditation programs.

The ACR awards the CBIC designation to centers that are fully accredited in mammography, stereotactic breast biopsy, breast ultrasound, including the ultrasound-guided breast biopsy module, and breast MRI. The designation recognizes a center's commitment to quality assurance and improving women's health through comprehensive breast imaging services.

The Center for Women's Imaging at Mercy is a dedicated breast imaging and diagnostic center located at The Weinberg Center at Mercy in downtown Baltimore. The Center's radiologists specialize in the diagnosis, screening and prevention of breast cancer and breast disease. Services include screening and diagnostic 3D mammography, breast ultrasound, breast MRI, breast biopsies and imaging-guided localization procedures.

The CBIC designation is based on the ACR's comprehensive accreditation requirements for breast imaging. According to the ACR, the designation provides recognition of a facility's commitment to quality and includes a comprehensive assessment of the medical imaging facility, an ongoing process for self-assessment and recognition among patients, providers, payers and administrators.

"We are extremely proud that the Tyanna O'Brien Center for Women's Imaging at Mercy has earned this important recognition from the American College of Radiology," said Deepa Masrani, M.D., Director, Center for Women's Imaging at Mercy. "This designation reflects the commitment of our entire breast imaging team to providing high-quality imaging and diagnostic services for the women we serve."

The Tyanna O'Brien Center for Women's Imaging is part of Mercy's broader commitment to comprehensive breast care. Mercy introduced advanced Genius™ 3D Mammography™ exams featuring 3DQuorum technology in 2024. The technology provides three-dimensional breast imaging designed to address the effects of overlapping breast tissue that can make abnormalities more difficult to detect on conventional mammography.

Since earlier this year, Mercy has been offering Contrast Enhanced Digital Mammograms, a highly effective diagnostic tool in the early detection of breast cancer.

Facilities that achieve and maintain the ACR's Comprehensive Breast Imaging Center designation are invited to participate in the ACR National Mammography Database (NMD).

Participation allows centers to benchmark practice performance, compare processes and outcomes with similar practices nationwide, identify opportunities for quality improvement and receive reports every six months.

The ACR's CBIC designation remains in effect as long as the center's required breast imaging services maintain their ACR accreditations.

The Tyanna O'Brien Center for Women's Imaging at Mercy is located at 227 St. Paul Place in Baltimore and can be reached at 410-332-9102. Below is a list of the Center's patient services:

- Digital 3D Mammography

- Screening 3D Mammograms (Tomosynthesis)

- Diagnostic 3D Mammograms (Tomosynthesis)

- Breast Ultrasound - Diagnostic Ultrasound and Whole Breast Ultrasound for Screening

- Screening and Diagnostic Breast MRI

- Image-guided Minimally Invasive Breast Biopsies 

- Ultrasound-guided Breast Biopsy

- Ultrasound-guided Fine Needle Aspiration

- Stereotactic Breast Biopsy, including Tomosynthesis-guided Biopsy

- MRI-guided Breast Biopsy

- Image-guided Needle Localization Procedures, including "Smart Clip" Localizations

- Formal Cancer Risk Assessment (performed for all patients)

Founded in 1874 in Baltimore by the Sisters of Mercy, Mercy Medical Center is a nonprofit Catholic health care organization and teaching hospital. Mercy has been recognized nationally by both U.S. News and World Report and Newsweek for its achievements in the field of orthopedic surgery.

For more information, visit Mercy online at www.mdmercy.com; MDMercyMedia on Facebook and Twitter(X); www.youtube.com/mmcbaltimore; or call 1-800-M.D.-Mercy.

Media Contact:

Dan Collins

Senior Director of Media Relations

Mercy Health Services / Mercy Medical Center

Office: 410-332-9714

Cell: 410-375-7342

Email: [email protected]

SOURCE Mercy Medical Center

Share this article

Home Genius Exteriors Named the #1 Fortune Best Workplaces in Construction™ 2026 (Small and Medium)

2026 recognition marks Home Genius Exteriors' fifth consecutive year on the list

HYATTSVILLE, Md., Oct. 6, 2026 /PRNewswire/ -- Home Genius Exteriors has been named #1 on the Fortune Best Small and Medium Workplaces in Construction™ 2026, marking the company's fifth consecutive appearance on the list. Additionally, Home Genius Exteriors was named the #2 on the Fortune Best Medium Workplaces™ 2026 list and #64 on the 2026 PEOPLE® Companies that Care list. Great Place To Work® and Fortune announced the recognition today. This marks Home Genius Exteriors' fifth appearance on the Best Workplaces in Construction list, following previous recognitions in 2022, 2023, 2024, and 2025.

"Being named one of Fortune Best Workplaces five years in a row matters because it comes back to our people," said Jeff Gunhus, CEO of Home Genius Exteriors. "They are the ones building the culture every day, supporting our neighbors, growing into new opportunities, and helping us become a stronger company. Awards are great, but the real win is creating a place where people are proud to work and excited about what they can become here."

To determine the 2026 list, Great Place To Work analyzed confidential survey feedback from 64,000 employees working across the U.S. construction industry.

Home Genius Exteriors' inclusion on the list reflects the company's ongoing investment in its people, from career development and leadership training to the community give-back culture championed through Home Genius Cares, the company's community impact initiative. As Home Genius Exteriors continues its rapid and successful national expansion, it continues to prioritize cultivating a workplace where employees are supported, valued, and empowered to grow. The recognition adds to a growing list of workplace honors for Home Genius Exteriors and reinforces the company's belief that strong business results start with putting people first.

Additional information on the Fortune Best Workplaces in Construction™ list is available at https://www.greatplacetowork.com/.

About Home Genius Exteriors

Home Genius Exteriors is a multi-state home improvement company providing roofing, siding, windows, exterior doors, gutters, and attic insulation. The company focuses on helping homeowners protect and improve their homes through clear communication, quality installation, and a people-first customer experience. Home Genius Exteriors serves homeowners nationwide and is built around its promise to deliver A Different Experience in home improvement.

For more information, visit www.homegeniusexteriors.com.

To explore career opportunities, visit www.homegeniusexteriors.com/careers.

About Home Genius Cares

Home Genius Cares is the community impact arm of Home Genius Exteriors, created to turn the company's people-first values into action. Through employee-led volunteerism, nonprofit partnerships, veteran initiatives, roof deployments, and local community events, Home Genius Exteriors employees support veterans, families, children, and organizations in the communities where they live and work.

SOURCE Home Genius Exteriors

Share this article

CLEVELAND, Oct. 6, 2026 /PRNewswire/ -- The Board of Directors of Avient Corporation (NYSE: AVNT), an innovator of materials solutions, has declared a quarterly cash dividend of twenty-eight and a quarter cents ($0.2825) per share on the common stock outstanding, representing the sixteenth consecutive annual increase.

The $0.2825 per share will be paid on January 7, 2027, to stockholders of record on December 11, 2026. On an annualized basis, the dividend will increase from $1.10 to $1.13 per share on the common stock outstanding.

"We are pleased to increase our dividend for the sixteenth consecutive year," said Dr. Ashish Khandpur, Chairman, President and Chief Executive Officer, Avient Corporation. "Our consistent dividend growth reflects the strength of our business, our strong cash flow generation, and our commitment to returning value to shareholders through a disciplined and balanced capital allocation strategy."

About Avient

Our purpose at Avient Corporation (NYSE: AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world. Our local touch and customer engagement, combined with our global presence, allows us to serve customers with agility. We harness the collective strength of 9,000 employees worldwide to collaborate and build on each other's ideas. In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends. Our expanding portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema®, the world's strongest fiber™. By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable. Visit www.avient.com to learn more.

SOURCE Avient Corporation

Share this article

DENVER, Oct. 6, 2026 /PRNewswire/ -- Gates Industrial Corporation Ltd. (NYSE:GTES) will issue its third-quarter earnings release before the market opens on Friday, October 30, 2026. Management will host a webcast and conference call on the same day at 10:00 a.m. Eastern time to discuss Gates Industrial's financial results. The conference call can be accessed as follows:

- By dialing +1 (833) 461-5787 (domestic) or +1 (585) 542-9983 (international) and requesting the Gates Industrial Corporation third-quarter 2026 Earnings Conference Call or providing the Conference ID of 624 981 852.

- Live webcast accessed through Gates Industrial's website at investors.gates.com.

An audio replay of the conference call will be available from approximately 1:00 p.m. Eastern time on October 30, 2026, until 11:59 p.m. Eastern time on November 6, 2026, and can be accessed domestically or internationally by dialing +1 (929) 828-5978 or +1 (833) 309-1852, respectively, and providing the passcode 624 981 852, or by accessing Gates Industrial's website at investors.gates.com.

About Gates Industrial Corporation Ltd.

Gates is a global manufacturer of innovative, highly engineered power transmission and fluid power solutions. Gates offers a broad portfolio of products to diverse replacement channel customers, and to OEMs as specified components. Gates participates in many sectors of the industrial and consumer markets. Our products play essential roles in a diverse range of applications across a wide variety of end markets ranging from harsh and hazardous industries to everyday consumer applications including virtually every form of transportation. Our products are sold in more than 130 countries across our three commercial regions: the Americas; Europe, Middle East & Africa; and Asia Pacific.

SOURCE Gates Industrial Corporation Ltd.

Share this article

MIDDLETOWN, Del., Oct. 6, 2026 /PRNewswire/ -- The global Tubeless Tires Market was valued at USD 150.001 billion in 2025 and is projected to expand from USD 157.501 billion in 2026 to USD 257.192 billion by 2035, registering a compound annual growth rate of 5.60% during the forecast period, according to the latest market intelligence study published by Radial Insights.

Tubeless construction has become the global standard across new passenger cars and light vehicles, while the next major growth phase is emerging from two-wheeler conversion in India and Southeast Asia, expanding replacement demand and increasing consumer preference for puncture-safe, lower-maintenance tire systems. OEM specifications, regulatory standards and improvements in air retention, rolling resistance and repairability are reinforcing adoption across passenger, motorcycle, commercial and selected off-road applications.

The new "Tubeless Tires Market Size, CAGR & Forecast, 2025-2035" study spans 245 pages and evaluates the market by vehicle type, rim type, sales channel, application, region climate and sealant use. The analysis covers OEM and aftermarket demand, passenger cars, two-wheelers, LCVs, commercial trucks and buses, OTR applications, standard and self-sealing tubeless systems, regional adoption patterns, competitive positioning and investment opportunities.

Near-Universal OEM Tubeless Fitment Establishes a Structural Demand Base

Global tubeless-tire demand is structurally supported by original-equipment fitment because every newly produced passenger or light vehicle creates an initial set of tubeless tires and establishes a future replacement cycle built around the same construction. OICA reported 96.4 million vehicles produced worldwide in 2025, up from 92.7 million in 2024, keeping OEM pull on tire manufacturing capacity elevated across major automotive markets.

The technology has already displaced tube-type construction across mainstream passenger vehicles. Michelin states that nearly all modern passenger-car tires are tubeless, while Bridgestone India says almost all new cars now use tubeless OE fitment. The architecture supports sealed rims, innerliner-based air retention and high-speed radial performance across passenger cars, crossovers, SUVs and pickup-derived light vehicles, making tubeless technology the reference standard rather than a premium exception.

This installed base also shapes the aftermarket because consumers replacing original tires generally remain within the tubeless ecosystem. Advanced alternatives such as airless tires remain comparatively early in commercialization, while manufacturers continue to invest in tubeless products aligned with new OEM requirements. Radial Insights estimates that near-universal OEM fitment contributes approximately 0.6 percentage points to overall market CAGR through 2035.

Key Insights From Radial Insights' Tubeless Tires Study

- Asia-Pacific Leads Global Demand: Asia-Pacific accounted for 51.64% of global tubeless tire demand in 2025, supported by high vehicle production, expanding two-wheeler sales and strong aftermarket activity.

- Passenger Cars and Two-Wheelers Lead Adoption: Passenger vehicles provide the largest installed base, while motorcycles and scooters represent the strongest conversion opportunity in emerging Asian markets.

- OEM Fitment Sets the Technology Standard: Near-universal tubeless installation on new passenger and light vehicles creates recurring replacement demand and normalizes compatible rims, valves and service practices.

- Replacement Conversion Expands in Emerging Markets: Puncture-safety, heat-dissipation and fuel-efficiency advantages are encouraging users to move away from legacy tube-type products.

- Self-Sealing Systems Create Premiumization: Sealant-enabled products are gaining attention in premium and high-utilization applications where reduced puncture downtime can justify higher prices.

Two-Wheeler Formalization Accelerates Tube-to-Tubeless Conversion

India and Southeast Asia provide one of the largest remaining conversion opportunities because high-volume motorcycle and scooter markets are moving toward organized OEM and dealer channels where tubeless fitments, standardized markings and compatible rims are increasingly common. SIAM reported 20.50 million two-wheeler sales in India in calendar 2025, while Indonesia recorded 6.41 million domestic motorcycle sales, giving these markets significant influence over the global two-wheeler tire mix.

Regulation and OEM product strategies are reinforcing this transition. India applies BIS certification under IS 15627 for pneumatic tires used on two- and three-wheeled motorcycles and requires tubeless products to carry appropriate TUBELESS or TL markings. High-volume models including Honda Activa variants and selected Yamaha and Honda products in Southeast Asia increasingly specify tubeless tires, expanding consumer familiarity and service-network capability.

As organized distribution expands, value shifts toward tubeless valves, compatible rims and higher-specification motorcycle radials. Apollo has also reported approvals from Triumph, KTM and Husqvarna for next-generation steel-belted radial motorcycle tires. Radial Insights estimates that two-wheeler formalization and conversion contribute approximately 0.9 percentage points to market CAGR, the largest modeled incremental contribution among the report's quantified drivers.

Get Sample Report - https://www.radialinsights.com/report/tubeless-tires-market

Puncture Safety and Lower TCO Expand Replacement-Channel Conversion

In emerging-market replacement channels, the shift from tube-type to tubeless tires is increasingly driven by total-use economics rather than construction preference alone. Tubeless tires generally lose air more slowly after a small puncture, eliminate the separate inner tube and can often be repaired without removing the entire tire from the rim. These characteristics reduce roadside disruption for commuters, delivery riders and small commercial fleets that depend on vehicle availability for daily income.

Bridgestone India highlights slower pressure loss, easier puncture repair, improved heat dissipation and lower weight as important advantages over tube-type products, while Harley-Davidson similarly notes that tubeless assemblies generally run cooler, weigh less and can support efficiency. The benefits are particularly relevant in dense urban markets where punctures, heat and frequent stop-start operation increase maintenance exposure.

The technology ladder is also widening beyond standard tubeless construction. Michelin Selfseal is designed to maintain pressure after selected punctures, while manufacturer-approved repair kits support temporary restoration of mobility for minor tread-area damage. These developments give manufacturers additional room to differentiate on safety and uptime. Radial Insights estimates that puncture-safety and fuel-efficiency benefits contribute approximately 0.5 percentage points to overall market CAGR through 2035.

Self-Sealing Technology Creates a Premium Tubeless Opportunity

Standard tubeless tires remain the mainstream choice because they balance cost, performance and serviceability, but self-sealing systems are creating a higher-value subsegment. Integrated sealants can automatically close selected tread punctures or slow pressure loss, reducing the likelihood that a driver or fleet operator must stop immediately for roadside service. The value proposition is strongest in premium passenger vehicles, commercial applications and markets with poor road surfaces or elevated puncture risk.

For manufacturers, sealant technology provides a path to premiumization without changing the basic tubeless architecture already used by OEMs and service networks. Product development is therefore expanding around sealant chemistry, innerliner compatibility, TPMS integration and climate-specific performance. The report identifies innovation in self-sealing and puncture-resistant products as an important opportunity for suppliers seeking differentiation beyond conventional volume growth.

Tubeless Tires Market Snapshot, 2025-2035

Market Challenges

High initial costs and price sensitivity can slow tube-to-tubeless conversion in cost-conscious markets. Consumers and small fleet operators may prioritize the lowest upfront tire price even when tubeless construction offers better puncture behavior, easier repairs and lower maintenance over the product lifecycle. Manufacturers therefore need to balance product quality, localized pricing and service availability to sustain adoption in emerging markets.

Supply chain complexity creates another constraint. Tubeless tires depend on consistent innerliner materials, compatible rims, valves, steel reinforcement and increasingly advanced sealant systems, leaving manufacturers exposed to volatility in natural rubber, synthetic polymers, steel cord and specialty chemical inputs. Logistics disruptions or insufficient local component availability can slow conversion and raise finished-product costs.

Technology adoption also varies by vehicle class and geography. Passenger cars are already highly radialized and tubeless, but parts of the two-wheeler, commercial and off-road markets retain tube-type or legacy designs. Expanding the addressable market therefore requires certification, dealer training, compatible wheel systems and consumer education rather than tire production alone.

Recent Industry Developments

- In October 2025, Goodyear launched Wrangler Outbound AT, Wrangler Workhorse AT 2 and Wrangler ElectricDrive AT across its consumer portfolio. The launches expand premium tubeless fitments for SUVs, light trucks, work vans and electric vehicles, strengthening replacement demand across utility-oriented applications.

KNOWIDEA Launches VeriPIE to Reduce Decision Risk with Verified AI Predictions

The Verified Predictive Intelligence Engine is available and in production at energy producers, financial institutions and manufacturers.

TORONTO, Oct. 6, 2026 /PRNewswire/ -- KNOWIDEA launches VeriPIE, the Verified Predictive Intelligence Engine. VeriPIE connects to a company's existing systems, predicts what happens next and what it is worth, and verifies every number in the recommendation.

VeriPIE is available today in the KNOWIDEA platform and in production with a Fortune 500 oil and gas producer, financial institution and industrial manufacturer.

Most companies decide using dashboards that describe the past, consulting reports that take eight to twelve weeks, or AI answers that are right most of the time. When a decision rests on a number no one can check, the risk sits with the executive's intuition.

VeriPIE runs the same five steps on every question. It connects ERP, finance, operations and CRM data with external benchmarks, finds the drivers of the number in question, forecasts each option, weighs each prediction against the company's risk tolerance, and delivers a recommendation with the judgments that need a human owner marked.

Each number traces to its source system, table, rows and dates. Claims that can be checked exactly are checked by code, not by another model. When evidence is missing, VeriPIE does not issue a verified recommendation and names the missing input.

"Every major decision is a prediction. The question is whether you can prove it before you bet the company on it. VeriPIE gives you the future with the work shown," said Yatharth Sejpal, Co-founder and CEO of KNOWIDEA.

"Prediction without verification is a guess with better formatting. VeriPIE proves every part of a forecast that can be proven and names the part that cannot," said Brian Zhengyu Li, Co-founder and CTO of KNOWIDEA.

VeriPIE sits on top of the ERP, data warehouse and BI tools a company already owns. To see it on your own data, bring one decision to a 30-minute session at knowidea.dev.

About KNOWIDEA

KNOWIDEA is a Toronto-based decision intelligence company. Learn more at knowidea.dev.

Media contact: Yatharth Sejpal, [email protected]

SOURCE KNOWIDEA

Share this article

27 Village Medical Houston clinics joining Harbor to become the care home for Harbor plans, which have no deductible; individual and family enrollment opens Nov. 1, alongside large employer plans across Texas

HOUSTON, Oct. 6, 2026 /PRNewswire/ -- Harbor Health, a Texas-based primary and specialty care clinic group and health insurance company, today announced it has signed an agreement to acquire 27 Village Medical clinics in Greater Houston, a well-established network with deep roots throughout the community. The acquisition brings Harbor to the largest city in Texas, weeks before Harbor individual and family plans become available to Houstonians for the first time.

Houston will become the fifth Texas market where Harbor both delivers care and provides coverage, joining Austin, Dallas, San Antonio and El Paso. When the transaction closes, expected at the end of the year, Harbor will operate nearly 70 clinics and more than double its number of physicians and advanced practice providers across the state. Financial terms were not disclosed.

"We started Harbor because we believe people deserve a better health care system and at the center of that is a company that is accountable for keeping you healthy," said Tony Miller, Harbor Health Co-Founder and CEO. "Village Medical Houston's clinicians have spent years changing how care is practiced. When we set out to build the best payvider in Texas, Houston was always central to it. Together, Houstonians have a new company that delivers their care, pays for it, and answers for both."

One company that delivers the care and pays for it

Members who choose a Harbor plan in Houston will have Village Medical Houston as their primary care home, with clinics serving Harris, Montgomery, Fort Bend and Brazoria counties. That is where a guided health journey begins. Harbor plans have no deductible, and when members start with a Harbor clinician and that clinician refers them to a specialist, the referred care is covered at $0. Because care and coverage are designed together, members are not left to sort out what is covered or where to go next.

Large employer plans are available now across 29 Texas counties, including Harris, Montgomery, Fort Bend and Brazoria in Greater Houston. Together, the 29 counties are home to more than 22 million Texans. Individual and family plans will be available on HealthCare.gov for 2027, with enrollment opening Nov. 1 in 13 of the 29 counties and coverage effective Jan. 1. Texas families and employers can learn more about Harbor plans at harborhealth.com.

"Making health care affordable is essential and that means having coverage that enables people to invest in health," said Dr. Clay Johnston, Harbor Health Co-Founder and Chief Innovation Officer. "When the people responsible for a person's health also help shape what their coverage pays for and when, it becomes easier for people to get the care we know works and to avoid waste."

What this means at Village Medical Houston

The Village Medical Houston clinics Harbor is acquiring will join the Harbor Health Insurance Company provider network and will continue to operate under the Village Medical name. Consumers who receive care at these clinics do not need to take any action, and the clinics will continue to accept the insurance plans they accept today.

"I grew up in Houston, and I spent nearly three years working at Village Medical, so I know many of these clinicians and care teams and the quality of care they deliver," said Erin Page, Harbor Health President and Chief Operating Officer. "Harbor was built around clinicians, and adding this team makes us stronger. To everyone joining us: welcome. We are excited to build with you."

For Houston brokers and employers

Large employer plans are available now to Houston-area employers, and individual and family enrollment opens Nov. 1. Brokers who want to sell Harbor plans in Houston should get appointed with Harbor before Nov. 1. Visit https://harborhealth.com/partner/broker or contact the broker relations team at [email protected] or 844-504-1100 to learn more.

About Harbor Health

Harbor Health is a Texas-based health care company that puts care at the core. Harbor runs its own primary and specialty care clinics across Texas and builds health insurance around care designed by its clinicians, so care and coverage work as one. Health care keeps asking people to start over. Harbor was built so they don't have to. For more information, visit harborhealth.com.

SOURCE Harbor Health

Share this article